Indaptus Therapeutics, Inc. (INDP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Indaptus Therapeutics, Inc. (INDP) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

INDP Cash Flow Statement

Indaptus Therapeutics, Inc. (INDP) cash flow statement — 18-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-1.93M	-7.01M	-3.19M	-3.05M	-4.02M	-5.05M	-3.4M	-2.51M	-2.48M	-3.94M	-2.6M	-3.73M	-2.11M	-4.96M	-2.21M	-4.6M	-3.15M	-3.12M	-3.54M	-5.63M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	52.03%	-38.89%	6.04%	-21.55%	-62.16%	-28.21%	-30.51%	32.71%	-17.62%	20.67%	-17.69%	18.84%	33.08%	-59.16%	37.54%	18.27%	-143.15%	-277.64%	-269.86%	-226.55%
Net Income	-1.79M	-2.54M	-8.11M	-2.98M	-5.23M	-4.53M	-4.13M	-3.07M	-4.02M	-3.81M	-4M	-3.92M	-3.25M	-4.25M	-3.66M	-3.47M	-3.84M	-3.37M	-3.22M	-3.37M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	735	320	321	322	321	321	392	534	534	535	442
Stock-Based Compensation	-64.28K	227.18K	785.81K	0	180.76K	240.89K	304.12K	444.18K	782.85K	774.69K	745.52K	764.8K	728.47K	727.14K	637.63K	584.04K	904.39K	831.18K	673.8K	795.34K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	567.27K	0	0	0	0	0	0	0
Other Non-Cash Items	-5.34M	410.15K	-241.34K	55.02K	787.7K	0	0	0	0	0	0	-140.57K	-728.47K	-129.23K	-102.17K	-7.84K	0	-24.16K	0	0
Working Capital Changes	5.28M	-5.11M	4.38M	-134.55K	242.26K	-755.59K	431.18K	111.82K	754.46K	-905.21K	654.99K	-436.56K	570.72K	-1.31M	909.08K	-1.71M	-217.59K	-560.14K	-997.73K	-3.06M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	-5.23M	4.16M	206.91K	-571.69K	-762.34K	1.15M	173.67K	390K	-1.24M	408.26K	261.44K	280K	-1.63M	570.76K	-743.95K	-56.44K	-925.2K	-1.27M	-2.79M
Cash from Investing	-4M	0	0	0	0	0	0	0	0	0	0	7M	8M	2.14M	5.12M	-2.94M	-15.81M	-2.8M	451.6K	-1.65K
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-3.94K	-1.94M	0	0	0	-1.65K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1.18K	-1.35K	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	-106.02K	-110.23K	0	5.12K	2M	0	172.56K	451.6K	0
Cash from Financing	11.98M	0	5.87M	2.72M	6.28M	3.15M	1.8M	2.59M	38.06K	316.05K	0	0	0	0	0	0	0	0	363.06K	42.52M
Debt Issued (Net)	0	0	85.49K	233.28K	5.74M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	12M	0	6.32M	2.49M	588.01K	3.15M	2.14M	3M	39.54K	336.04K	0	0	0	0	0	0	0	0	0	-4.9M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-16.18K	0	-530.47K	0	-45.5K	0	-333.19K	-408.04K	-1.48K	-20K	0	0	0	0	0	0	0	0	363.06K	47.42M
Net Change in Cash	6.06M	-7.01M	2.68M	-332.06K	2.27M	-1.9M	-1.59M	78.94K	-2.44M	-3.62M	-2.6M	3.27M	5.89M	-2.82M	2.91M	-7.54M	-18.96M	-5.92M	-2.73M	36.89M
Free Cash Flow	-1.93M	-7.01M	-3.19M	-3.05M	-4.02M	-5.05M	-3.4M	-2.51M	-2.48M	-3.94M	-2.6M	-3.73M	-2.11M	-4.96M	-2.21M	-6.54M	-3.15M	-3.12M	-3.54M	-5.63M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	52.03%	-38.89%	6.04%	-21.55%	-62.16%	-28.21%	-30.51%	32.71%	-17.62%	20.67%	-17.48%	42.89%	33.08%	-59.16%	37.43%	-16.11%	-142.74%	-277.64%	-269.86%	-226.5%
FCF per Share	-0.02	-3.23	-1.47	-0.53	-0.70	-0.54	-0.36	-0.26	-0.29	-0.47	-0.31	-0.44	-0.25	-0.59	-0.27	-0.79	-0.38	-0.38	-0.87	-1.35
FCF Conversion (FCF/Net Income)	1.07x	2.76x	0.39x	1.03x	0.77x	1.11x	0.82x	0.82x	0.62x	1.03x	0.65x	0.95x	0.65x	1.17x	0.60x	1.33x	0.82x	0.93x	1.10x	1.67x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.78K	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4K	0	0	0